跳至主要内容
临床试验/NCT03543059
NCT03543059Unknown不适用

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Women With Breast Cancer

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2018年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
2,000
试验地点
1
主要终点
Pregnancy outcome

研究概览

简要总结

Breast cancer is one of the most common malignant tumor in women. About 60% of breast cancer patients are still in premenopausal status at the time of diagnosis in China. It is a multicenter prospective observational study. We will collect basic information, medical history, chemotherapy-related adverse reactions, and the results of hormone, blood lipid, and bone density test before, during and after adjuvant or neoadjuvant chemotherapy. The aim of the study is to evaluate the effect of chemotherapy on ovarian function and fertility and the protective effect of GnRHa. In addition, the collected information of the subjects are analyzed to provide suggestions for the relevant prevention strategy.

详细描述

Breast cancer is one of the most common malignant tumor in women, and it occurs at a younger median age in Chinese women than in western white women. About 60% of breast cancer patients are still in premenopausal status at the time of diagnosis in China. Chemotherapy is one of the important treatments for breast cancer, but it brings a series of adverse effects. It is a multicenter prospective observational study. The premenopausal breast cancer women patients who are planning adjuvant or neoadjuvant chemotherapy are enrolled in the study after signing the informed consent form and passing the screening. We collect their basic information, medical history, chemotherapy-related adverse reactions, and the results of hormone, blood lipid, and bone density test before, during and after chemotherapy. The aim of the study is to evaluate the effect of adjuvant or neoadjuvant chemotherapy on ovarian function and fertility and the protective effect of GnRHa by investigating the menopausal symptoms, pregnancy, menstruation condition, hormone levels, blood lipid, bone density, and the usage of GnRHa in the premenopausal women with breast cancer. In addition, the collected information of the subjects are analyzed to provide suggestions for the relevant prevention strategy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Informed consent form has been signed.
  • Breast cancer patients whose age is ≥ 18 years old and have been diagnosed by histological examination.
  • Plan for adjuvant or neoadjuvant chemotherapy

排除标准

  • Postmenopausal women who are defined by any of the following:
  • Previous bilateral oophorectomy;
  • Age ≥ 60 years old;
  • Age <60 years old, menopause at least 12 months, and follicle stimulating hormone [FSH] and estradiol levels in the postmenopausal range.
  • Those who have already received adjuvant or neoadjuvant chemotherapy.
  • Those who have chemotherapy contraindications.
  • Those who have any mental condition that prevents the understanding of the contents of this study and can't provide the complete information required.

研究组 & 干预措施

exposure group

exposed to some factors

干预措施: GnRH analogue (Drug)

结局指标

主要结局

Pregnancy outcome

时间窗: 5 years

The number of patients reporting pregnancy and attempting pregnancy

次要结局

  • Rate of ovarian failure(2 years)

研究者

发起方
Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

wang shusen

Professor

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验